Predictive and prognostic role of fragile histidine triad (FHIT) and P53 gene inactivaton in non-small-cell lung cancer (NSCLC) patients treated with platinum-analogue regimen

被引：0
|
作者：
Cortinovis, D.
Bajetta, E.
Sozzi, G.
Mariani, L.
Fabbri, A.
Livio, A.
Roz, L.
Andriani, F.
Perego, P.
Zilembo, N.
Formisano, B.
Bidoli, P.
机构：
[1] Ist Nazl Studio & Cura Tumori, Med Oncol Unit 2, I-20133 Milan, Italy
[2] Ist Nazl Studio & Cura Tumori, Dept Expt Oncol, I-20133 Milan, Italy
[3] Ist Nazl Studio & Cura Tumori, Dept Med Stat, I-20133 Milan, Italy
[4] Ist Nazl Studio & Cura Tumori, Anat Pathol Unit, I-20133 Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI19 / XI19
页数：1
相关论文
共 50 条
  • [1] Fragile histidine triad (FHIT) and p53 gene inactivaton as response markers in non-small-cell lung cancer (NSCLC) patients treated with platinum-analogue regimen: Retrospective analysis
    Cortinovis, Diego
    Bajetta, Emilio
    Sozzi, Gabriella
    Mariani, Luigi
    Fabbri, Alessandra
    Livio, Anna
    Roz, Luca
    Formisano, Barbara
    Zilembo, Nicoletta
    Bidoli, Paolo
    ANNALS OF ONCOLOGY, 2006, 17 : 253 - 253
  • [2] EXPRESSION OF FRAGILE HISTIDINE TRIAD AND P53 IN NON-SMALL CELL LUNG CANCER
    侯兴华
    张道荣
    Chinese Journal of Cancer Research, 2006, (02) : 121 - 126
  • [3] Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancers
    Y-L Chang
    C-T Wu
    J-Y Shih
    Y-C Lee
    British Journal of Cancer, 2003, 89 : 320 - 326
  • [4] Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancers
    Chang, YL
    Wu, CT
    Shih, JY
    Lee, YC
    BRITISH JOURNAL OF CANCER, 2003, 89 (02) : 320 - 326
  • [5] Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non-small-cell lung cancer
    Tsao, Ming-Sound
    Aviel-Ronen, Sarit
    Ding, Keyue
    Lau, Davina
    Liu, Ni
    Sakurada, Akira
    Whitehead, Marlo
    Zhu, Chang-Qi
    Livingston, Robert
    Johnson, David H.
    Rigas, James
    Seymour, Lesley
    Winton, Timothy
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5240 - 5247
  • [6] Prognostic relevance of p53, Bcl-2, and Bax expression in non-small-cell lung cancer (NSCLC)
    Dworakowska, D
    Faran, G
    Kobierska-Gulida, G
    Sygut, J
    Kopczynski, J
    Bosse, A
    Dorn, K
    Skokowski, J
    Jassem, J
    Jassem, E
    LUNG CANCER, 2004, 45 : S30 - S31
  • [7] Characteristics of P53 gene mutations in Polish non small cell lung cancer (NSCLC) patients
    Skrzypski, M
    Szymanowska, A
    Jassem, E
    Niklinski, J
    Jakobkiewicz-Banecka, J
    Dziadziuszko, R
    Kobierska-Gulida, G
    Rzyman, W
    Limon, J
    Jassem, J
    LUNG CANCER, 2005, 49 : S145 - S145
  • [8] Prognostic value of p53 abnormalities in non-small cell lung cancer (NSCLC)
    Niklinski, J
    Chyczewski, L
    Niklinska, W
    Laudanski, J
    Furman, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S248 - S248
  • [9] THE PREDICTIVE ROLE OF THE 53BP1 PATHWAY IN ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P) TREATED WITH FIRST-LINE PLATINUM-BASED CHEMOTHERAPY
    Bonanno, L.
    Costa, C.
    Majem, M.
    Gimenez-Capitan, A.
    Rodriguez, I.
    Sanchez, J. J.
    Massuti Sureda, B.
    Favaretto, A.
    Rugge, M.
    Rosell, R.
    ANNALS OF ONCOLOGY, 2012, 23 : 533 - 533
  • [10] P53 AND DISEASE PROGRESSION IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
    SAUTER, ER
    GWIN, JL
    MANDEL, J
    KELLER, SM
    SURGICAL ONCOLOGY-OXFORD, 1995, 4 (03): : 157 - 161
12345